| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-009-1317-6 |
| P698 | PubMed publication ID | 19957003 |
| P2093 | author name string | Filip Van den Bosch | |
| P2860 | cites work | Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 |
| Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis | Q34058697 | ||
| Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging | Q35549126 | ||
| The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients | Q35550247 | ||
| Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis | Q35550259 | ||
| Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age | Q35552212 | ||
| Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations | Q35553741 | ||
| ASAS/EULAR recommendations for the management of ankylosing spondylitis | Q35637012 | ||
| No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial | Q35760022 | ||
| The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice | Q35953515 | ||
| Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides | Q36245711 | ||
| Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 | Q40627164 | ||
| Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis | Q41868982 | ||
| How to diagnose axial spondyloarthritis early | Q42099745 | ||
| Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. | Q50960052 | ||
| The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. | Q51848128 | ||
| The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. | Q51848130 | ||
| Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study | Q61628505 | ||
| Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup | Q68098297 | ||
| Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients | Q72044965 | ||
| Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms | Q73299268 | ||
| Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging | Q73393619 | ||
| Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. | Q74460386 | ||
| Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT) | Q81364713 | ||
| P433 | issue | 3 | |
| P921 | main subject | ankylosing spondylitis | Q52849 |
| P304 | page(s) | 281-288 | |
| P577 | publication date | 2009-12-03 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations | |
| P478 | volume | 29 |
| Q38522331 | Biologics in spondyloarthritis: TNFα inhibitors and other agents |
| Q37944297 | Current therapeutics for spondyloarthritis |
| Q53730754 | The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis. |
Search more.